Yucai Wang

Mayo Clinic - Rochester / United States

Others

AD Scientific Index ID: 1341721

Mayo Clinic College of Medicine and Science

Go Premium -
Unlock Full Profile Tools

Get Your Global Impact Certificate

Yucai Wang's MOST POPULAR ARTICLES

1-) Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis JAMA oncology 5 (7), 1008-1019, 2019

2-) Representation of minorities and women in oncology clinical trials: review of the past 14 years Journal of oncology practice 14 (1), e1-e10, 2018

3-) Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma Journal of hematology & oncology 9 (1), 51, 2016

4-) Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in standard-of-care practice: results from the US lymphoma CAR T consortium Journal of Clinical Oncology 41 (14), 2594-2606, 2023

5-) Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center Haematologica 105 (3), 765, 2019

ARTICLES

Add your articles